You have 9 free searches left this month | for more free features.

Non-HIV

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pneumocystis Jirovecii Pneumonia Trial in Beijing (Radiomic model)

Active, not recruiting
  • Pneumocystis Jirovecii Pneumonia
  • Radiomic model
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Jan 25, 2023

Blood and Reproductive Fluids in HIV-Infected and

Recruiting
  • HIV
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Pneumocystis Jirovecii Pneumonia in Non-HIV-infected

    Active, not recruiting
    • Pneumocystis Jirovecii Infection
      • Vandoeuvre Les Nancy, Lorraine, France
        Université de Lorraine, CHRU Nancy and APEMAC
      Jul 12, 2022

      HIV, Non-Alcoholic Fatty Liver Disease, Metabolic-Associated Steatotic Liver Disease Trial in Nashville (Prebiotic, Probiotic)

      Not yet recruiting
      • HIV
      • +2 more
      • Prebiotic
      • Probiotic
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Oct 30, 2023

      HIV, Non-HIV, Vagus Nerve Dysfunction Trial in New York (Pyridostigmine, Placebos, non-invasive vagal nerve stimulation)

      Recruiting
      • HIV
      • +2 more
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Apr 12, 2022

      Incidence of Opportunistic Fungal Infections

      Not yet recruiting
      • Pneumocystis Jirovecii Infection
      • +4 more
        • (no location specified)
        Jan 30, 2023

        RZV Vaccine (Shingrix ®) Trial in France, Switzerland (Recombinant Zoster Vaccine)

        Not yet recruiting
        • RZV Vaccine (Shingrix ®)
        • Recombinant Zoster Vaccine
        • Bordeaux, France
        • +7 more
        Oct 27, 2022

        HIV-1-infection Trial (Delstrigo, KOCITAF)

        Not yet recruiting
        • HIV-1-infection
        • (no location specified)
        Jun 20, 2023

        People Living With HIV Treated With CD19-directed CAR T Cell

        Active, not recruiting
        • Leukemia
        • +9 more
          • Philadelphia, Pennsylvania
            Pennsylvania Hospital
          Mar 29, 2023

          AIDS Virus, Disorder of Immune Reconstitution Trial in Jinan (normal saline, Mesenchymal stem cells)

          Recruiting
          • AIDS Virus
          • Disorder of Immune Reconstitution
          • normal saline
          • Mesenchymal stem cells
          • Jinan, Shandong, China
            Shandong Public Health Clinical Center
          May 14, 2023

          Leukapheresis to Obtain Plasma or Lymphocytes for Studies of

          Recruiting
          • HIV
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jan 13, 2023

            HIV-infected Non-malarial Febrile Illnesses Using Metagenomic

            Recruiting
            • HIV Infection
              • Mulago, Uganda
                Baylor College of Medicine Children's Foundation-Uganda
              Oct 4, 2022

              Rates of Integration of AIDS Indicator Conditions Into Hospital

              Recruiting
              • HIV Infections
              • Non-interventional
              • Ankara, Turkey
                Ankara Eğitim ve Araştırma Hastanesi
              Dec 23, 2022

              HIV Trial in Boston (TRUVADA + raltegravir)

              Completed
              • HIV Infections
              • TRUVADA + Raltegravir
              • Boston, Massachusetts
                Fenway Community Health
              Oct 4, 2022

              HIV-1-infection Trial (Fostemsavir 600 MG [Rukobia])

              Recruiting
              • HIV-1-infection
              • Fostemsavir 600 MG [Rukobia]
              • Orlando, Florida
                Orlando Immunology Center
              Sep 20, 2022

              French CAC-HIV Cohort Study

              Completed
              • Coronary Artery Calcification
              • HIV Infections
              • Computed tomography coronary artery calcium (CAC) score (part of routine workup)
              • (no location specified)
              Oct 24, 2022

              NAFLD, NASH - Nonalcoholic Steatohepatitis, HIV Trial in Indianapolis, Boston (Vitamin E, Placebos)

              Active, not recruiting
              • NAFLD
              • +2 more
              • Vitamin E
              • Placebos
              • Indianapolis, Indiana
              • +1 more
              Feb 1, 2023

              Kaposi Sarcoma, HIV-1-infection Trial (Pegylated liposomal doxorubicin, Paclitaxel)

              Not yet recruiting
              • Kaposi Sarcoma
              • HIV-1-infection
              • (no location specified)
              Jan 20, 2023

              HIV, HIV Trial (Dolutegravir, Lamivudine, Bictegravir)

              Not yet recruiting
              • HIV
              • HIV Infections
              • (no location specified)
              Aug 4, 2023

              Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

              Recruiting
              • Diffuse Large Cell Lymphoma
              • +4 more
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Feb 2, 2023

              HIV, Bariatric Surgery Candidate Trial (bariatric surgery)

              Not yet recruiting
              • HIV Infections
              • Bariatric Surgery Candidate
              • bariatric surgery
              • (no location specified)
              Sep 9, 2022

              Tool to Describe HIV-Related Cancer Burden and Patient

              Not yet recruiting
              • HIV-Associated Malignant Neoplasm
              • +7 more
              • Non-Interventional
              • Non-Interventional Follow-up
              • (no location specified)
              Aug 18, 2022

              Hepatitis C Treatment Study in Myanmar

              Withdrawn
              • Hepatitis C
              • Sofosbuvir 400 mg
              • Yangon, Myanmar
                Medical Action Myanmar
              Dec 3, 2021

              HIV/AIDS Trial in Masaka (Intensive Adherence Counselling (IAC))

              Not yet recruiting
              • HIV/AIDS
              • Intensive Adherence Counselling (IAC)
              • Masaka, Uganda
                Kalisizo Hospital
              Aug 22, 2022

              NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)

              Not yet recruiting
              • NSCLC Stage IV
              • +4 more
              • Nivolumab and Ipilimumab
              • Verona, Veneto/Verona, Italy
                Centro Ricerche Cliniche
              Oct 26, 2022